Please login to the form below

Not currently logged in
Email:
Password:

Elliott Levy joins Amgen from BMS

He is appointed senior VP, global development

Dr Elliott Levy has left his role at Bristol-Myers Squibb to join Amgen as senior VO, global development.

Levy was most recently senior VP and head of specialty development at BMS, where he spent 17 years.

During this time he served in a number of senior roles including head of global pharmacovigilance and epidemiology.

“Elliott brings a wealth of development and leadership experience to his new role at Amgen,” said Dr Sean Harper, executive VP of R&D at Amgen.

“His track record shows his success in leading major clinical development programmes, and we're confident that he will help Amgen to serve patients by advancing the large number of potential new medicines in our late-stage pipeline.”

26th August 2014

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
SEVEN STONES

Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics